Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
383.00    2.00 (0.52%)
Bid:
378.00
Ask:
384.50
Spread: 6.50 (1.72%)
Market Cap: £1.96b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

14 Mar 2023 17:35

RNS Number : 9514S
Caledonia Investments PLC
14 March 2023
 

Caledonia Investments plc

 

Notification of transactions of persons discharging managerial responsibilities ("PDMR") or persons closely associated with them ("PCA")

 

Caledonia Investments plc ("Caledonia" or the "Company") has been notified pursuant to the requirements of the Market Abuse Regulation of the following transactions in its ordinary shares of 5p ("Shares") involving Jamie Cayzer-Colvin, a director and a person closely associated with him.

 

On 13 March 2023, Jellicoe No.2 Settlement - Grandchildren's Fund, of which Mr Cayzer-Colvin is a trustee, transferred 2,415 Shares in Caledonia, representing 0.004% of the Company's total issued ordinary share capital, to a beneficiary for nil consideration.

 

Mr Cayzer-Colvin's total interests in Shares following the above transaction is as follows: 

 

Beneficial - 250,024 Shares = 0.46%

Non-beneficial - 200,969 Shares = 0.37%

Performance share scheme awards - 74,708 Shares = 0.14%

Deferred bonus plan awards - 9,097 Shares = 0.02%

 

Further information required by the Market Abuse Regulation in relation to these transactions is set out in the appendix below.

 

Enquiries:

Richard Webster

Company Secretary

Tel: +44 20 7802 8080

 

14 March 2023

 

APPENDIX

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Jellicoe No.2 Settlement - Grandchildren's Fund

2

 

Reason for the notification

 

a)

 

Position/status

 

Person closely associated with James Cayzer-Colvin, a director

 

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Caledonia Investments plc

b)

 

LEI

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 5p shares

 

 

GB0001639920

 

b)

 

Nature of the transaction

 

Transfer to beneficiary

 

c)

 

 

Price(s) and volume(s)

 

 

 

 

 

Price(s)

 

Volume(s)

£nil

2,415

 

d)

 

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

n/a single tranaction

e)

 

Date of the transaction

 

13 March 2023

f)

 

Place of the transaction

 

London - outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBRGDXSXBDGXS
Date   Source Headline
30th Oct 20174:08 pmRNSDisposal
6th Oct 201711:33 amRNSNet Asset Value(s)
5th Oct 20178:45 amRNSHolding(s) in Company
3rd Oct 20179:21 amRNSHolding(s) in Company
29th Sep 201711:21 amRNSHolding(s) in Company
8th Sep 20178:48 amRNSDirectorate Change
6th Sep 20178:53 amRNSNet Asset Value(s)
21st Aug 20179:50 amRNSChange of Registered Office
18th Aug 20179:59 amRNSHolding(s) in Company
4th Aug 20173:46 pmRNSNet Asset Value(s)
24th Jul 20175:09 pmRNSDirector/PDMR Shareholding
20th Jul 20173:28 pmRNSResult of AGM
6th Jul 20173:11 pmRNSReport for quarter ended 30 June 2017
6th Jul 20172:51 pmRNSNet Asset Value(s)
6th Jul 20172:24 pmRNSIncrease in committed bank facilities
6th Jul 20171:11 pmRNSDirector/PDMR Shareholding
5th Jul 20173:22 pmRNSHolding(s) in Company
3rd Jul 20178:45 amRNSBlock listing Interim Review
29th Jun 20173:01 pmRNSDisposal
27th Jun 20177:00 amRNSCapital Markets Day
13th Jun 20179:14 amRNSAnnual Financial Report
12th Jun 20173:17 pmRNSDirector/PDMR Shareholding
8th Jun 20172:31 pmRNSDirector/PDMR Shareholding
7th Jun 20178:45 amRNSNet Asset Value(s)
25th May 20177:00 amRNSFinal Results 31 March 2017
8th May 201710:08 amRNSNet Asset Value(s)
5th May 20171:31 pmRNSHolding(s) in Company
7th Apr 201711:18 amRNSNet Asset Value(s)
31st Mar 20173:20 pmRNSTransaction in Own Shares
13th Mar 201712:36 pmRNSHolding(s) in Company
6th Mar 201712:30 pmRNSNet Asset Value(s)
8th Feb 20173:15 pmRNSDisposal
6th Feb 20171:22 pmRNSNet Asset Value(s)
6th Jan 20172:05 pmRNSInterim Management Statement 31 December 2016
6th Jan 20172:01 pmRNSNet Asset Value(s)
3rd Jan 20179:09 amRNSBlock listing Interim Review
19th Dec 20167:00 amRNSDisposal
13th Dec 20169:25 amRNSHalf-year Report
6th Dec 201612:32 pmRNSNet Asset Value(s)
24th Nov 20167:00 amRNSHalf-year Report
4th Nov 20169:20 amRNSNet Asset Value(s)
7th Oct 201610:42 amRNSNet Asset Value(s)
30th Sep 201611:26 amRNSTransaction in Own Shares
8th Sep 20161:36 pmRNSAcquisition
6th Sep 201611:55 amRNSNet Asset Value(s)
11th Aug 20169:04 amRNSForm 8 (DD) - Avanti Communications Group plc
10th Aug 20169:25 amRNSForm 8.3 - Avanti Communications Group plc
4th Aug 20163:57 pmRNSHolding(s) in Company
4th Aug 20162:31 pmRNSNet Asset Value(s)
22nd Jul 201612:55 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.